DEC 03, 2018 03:00 PM PST

Using bubbly nano-particles for chemotherapy delivery

We have all heard about the harsh side effects of chemotherapy that could be so difficult leading to stopping treatment. The reason behind those side effects is that chemotherapy drugs do target not only cancer cells but also the healthy cells of the body. So what if there was a way to solely target cancer cells without damaging normal cells.

Sofie, a Research Scientist at SINTEF’s Department of Biotechnology and Nanomedicine in Trondheim and a Postdoc at the Department of Physics at Norwegian University of Science and Technology (NTNU), is trying to achieve this by using nanoparticles and bubbles.

Her talk at the TEDx event was about her research on bubbly nanoparticles containing a chemotherapeutic drug, that when combined with ultrasound radiation at the target tissue, it creates a local force that disperses the nanoparticles to a broader area of cancer cells without affecting the rest of the body, which means fewer side effects and better treatment. The drug-loaded nanoparticles can be altered to when and where it will be degraded to evacuate the drug inside the cancer cells leading to its death.

This technology is promising also for brain diseases as nanoparticles can pass the blood-brain barrier into the brain cells leading to the possibility of using it with drugs for known diseases with no cure yet as Alzheimer's and Parkinson's.

Other research on the use of ultrasound with nanoparticles and the use of nanoparticles in cancer are also included.

Sources: Youtube, ScienceDirect, Hindawi

About the Author
  • A master student in Biochemistry and Molecular biology with experience in Education and Research. I am passionate about scientific research and passing my knowledge to others to help them learn about the latest in science by teaching, writing and volunteering in scientific events.
You May Also Like
AUG 14, 2018
Cancer
AUG 14, 2018
Using Arsenic to Enhance Cancer Therapies Beyond Leukemia
An already existing combination of arsenic and all-trans retinoic acid is found to inhibit a key signaling pathway that exerts broad effect on oncogenic processes for some solid tumors....
AUG 26, 2018
Cancer
AUG 26, 2018
Can antireflux surgery prevent Esophageal cancer?
Heartburn or gastroesophageal reflux disease (GERD) is a widespread health problem affecting 10 to 20% of adults in Western populations. If GERD left untre...
AUG 30, 2018
Genetics & Genomics
AUG 30, 2018
Genetic Changes can Help Diagnose Childhood Cancers Far Earlier
New research has revealed genetic rearrangements that happen far before bone cancer starts growing in children....
SEP 26, 2018
Cancer
SEP 26, 2018
Rare Cancer the Focus of Mesothelioma Awareness Day
More than 2,500 Americans are diagnosed with mesothelioma cancer each year. The cancer is rare but very serious - most patients diagnosed with the disease live just a short 12 to 21 months....
OCT 05, 2018
Cancer
OCT 05, 2018
FDA approves a new drug for an advanced type of skin cancer
As cancer is one of the most challenging diseases in our world, many efforts have been put into researching new ways for treatment to find new drugs that could help more patients worldwide. A...
DEC 16, 2018
Health & Medicine
DEC 16, 2018
Important Biomedical Research At Risk Of Being Defunded
In September the Department of Health and Human Services (D.H.H.S.) released a statement citing “serious regulatory, moral and ethical considerations...
Loading Comments...